An Efficacy Study of Chlorhexidine Mouthwashes
Clinical Study to Evaluate the Efficacy of Chlorhexidine Mouthwashes
1 other identifier
interventional
324
1 country
3
Brief Summary
The aim of this study is to compare subject gingival health after 6 weeks of twice daily use of a non-alcohol or alcohol containing mouthrinse and brushing compared to brushing only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Oct 2012
Shorter than P25 for phase_4
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 13, 2012
CompletedFirst Posted
Study publicly available on registry
December 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedResults Posted
Study results publicly available
July 28, 2014
CompletedJuly 28, 2014
June 1, 2014
5 months
December 13, 2012
May 1, 2014
July 3, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Gingival Severity Index (GSI) Based on the Gingival Index (GI)
Measure of gingival severity averaged across whole mouth site; each site scored 0, 1, 2, 3 based on GI and, 1. GSI = 0 if GI is 0 or 1 (no bleeding) 2. GSI = 1 if GI is 1 or 2 (bleeding)
Change from baseline to 6 weeks
Secondary Outcomes (3)
Gingival Index
Change from baseline to 6 weeks
Turesky Modification of Quigley & Hein Plaque Index for Overall Plaque Scores
Change from baseline to 6 weeks
Turesky Modification of Quigley & Hein Plaque Index for Interproximal Plaque Scores
Change from baseline to 6 weeks
Study Arms (2)
Mouthwash with Alcohol
ACTIVE COMPARATORrinse with 10ml 0.2% w/v Chlorhexidine Digluconate Mouthwash with alcohol for 1 timed minute twice daily for 6 weeks following brushing with a full brush head of standard toothpaste for 1 timed minute.
Mouthwash without Alcohol
ACTIVE COMPARATORrinse with 10ml 0.2% w/v Chlorhexidine Digluconate Mouthwash without alcohol for 1 timed minute twice daily for 6 weeks following brushing with a full brush head of standard toothpaste for 1 timed minute.
Interventions
0.2% w/v Chlorhexidine Digluconate, alcohol containing - UK Marketed Mouthwash
0.2% w/v Chlorhexidine Digluconate, without alcohol - UK Marketed Mouthwash
Eligibility Criteria
You may qualify if:
- Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or oral/ dental examination.
- \. a) Good oral health in the opinion of the investigator (allowing mild to moderate gingivitis to meet entry criteria).
- b) A minimum of 20 permanent gradable teeth at screening. (Gradable teeth are those where restorative materials cover less than 25% of the tooth surface graded).
- c) Mild to moderate gingivitis present at the screening visit in the opinion of the investigator.
- d) Positive response to bleeding on brushing exercise at screening visit. e) A total of 20 bleeding sites or greater at baseline visit.
You may not qualify if:
- Known or suspected intolerance or hypersensitivity to Chlorhexidine or other study materials (or closely related compounds) or any of their stated ingredients.
- \. a) Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any other medical condition (e.g. Diabetes Mellitus) that would make the subject unlikely to fully complete the study or any that increases the risk to the subject or undermines the data validity.
- b) Subjects requiring prophylactic antibiotic treatment prior to dental therapy.
- c) Use of concomitant medication that, in the opinion of the investigator, might interfere with the outcome of the study or increases the risk to the subject (eg: phenytoin, calcium antagonists, cyclosporine, warfarin, antibiotics, immuno-suppressants).
- d) Use of antibiotics within two weeks prior to the screening visit or throughout the study.
- e) Use of any systemic medication which would have an effect on gingival conditions within 14 days of gingival examinations (eg: ibuprofen or aspirin therapy) 6. a) Have current active caries b) More than 3 pockets with 5mm or over. c) Excessive calculus present that interferes with the probing examination for Gingival Index.
- d) Other severe oral/ gingival conditions (e.g. Acute Necrotizing Ulcerative Gingivitis) that may compromise the study or the subjects in the opinion of the investigator or gingivitis examiner.
- e) Medical conditions which may directly influence gingival bleeding. f) Restorations in a poor state of repair. g) Orthodontic appliances anterior cosmetic restorations and veneers. h) Enamel pitting/irregularities. 7. Subjects using chewing tobacco, pan, pan-masala, gutkha or other chewing tobacco products or subjects who have quit using any of those within the past six months prior to screening.
- \. b) An employee of any toothpaste manufacturer or their immediate family.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
Study Sites (3)
Intertek 4-Front Research - Widnes
Widnes, Cheshire, WA8 6PG, United Kingdom
4Front, Ellesmere Port
Cheshire, CH65 4BW, United Kingdom
Intertek - Manchester Science Park
Manchester, M15 6SE, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- GSK Response Center
- Organization
- GlaxoSmithKline
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
GlaxoSmithKline
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2012
First Posted
December 17, 2012
Study Start
October 1, 2012
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
July 28, 2014
Results First Posted
July 28, 2014
Record last verified: 2014-06